Delivery Order SPE2DB22D2007-SPE2DB24FJ2QM
Award Date
5/20/24
Potential Completion Date
6/11/24
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Zeposia 0.92 mg capsules. The award, valued at $17,866.28, is a delivery order contract placed by the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price pricing type and an ultimate completion date of July 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Zeposia 0.92 MG Capsule 30S to the Defense Logistics Agency (DLA), a defense agency. The $4,466.57 firm fixed price contract has an ultimate completion date of May 29, 2024. Amerisourcebergen also holds a much larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical division through December...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Zeposia 0.92 mg capsules in a 30-count package to the Defense Logistics Agency (DLA), a defense agency. The $17,866.28 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $4,466.57 firm-fixed-price delivery order is for the pharmaceutical product ZEPOSIA 0.92 MG CAPSULE 30S, with an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical through December 31,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $4,620.93 for the supply of the drug Zeposia 0.92 mg capsules. The contract, awarded by the Defense Logistics Agency (DLA), has a completion date of December 23, 2024 and utilizes a firm fixed price pricing structure. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,620.93 firm fixed-price delivery order is for the supply of Zeposia 0.92 mg capsules, a specialty medication. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $8,933.14 to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through August 2, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4564688600 ZEPOSIA 0.92 MG CAPSULE 30S, with an ultimate completion date of June 13, 2024. The $8,933.14 firm-fixed-price delivery order was awarded on May 22, 2024 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a major pharmaceutical distribution company, holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025 with...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Zeposia 0.92 mg capsules. The $4,466.57 order has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,466.57 award is for the supply of the medication Zeposia 0.92 mg capsules. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to...